Source: BioPortfolio

Accelovance: Accelovance Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 11072018 Prices from USD $250

SummaryAccelovance Inc Accelovance is a contract research organization that provides CRO services patient recruitment and clinical call center services in various therapeutic areas including oncology immunization and infectious disease CNS renal care and o...

Read full article »
Accelovance's Competitors | Accelovance's News | Accelovance's Financials
Stay up-to-date with the latest news on Linical Accelovance
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Vita Lanoce's photo - CEO of Linical Accelovance

CEO

Vita Lanoce

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Linical Accelovance